Clinical Trial Results:
A Phase 3 Randomized, Placebo- and Active Comparator-Controlled Clinical Trial to
Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic
Patients with Schizophrenia
Summary
|
|
EudraCT number |
2007-003820-40 |
Trial protocol |
LT |
Global completion date |
31 Jan 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Dec 2016
|
First version publication date |
04 Dec 2016
|
Other versions |
|
Summary report(s) |
D10650231 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.